Wattacheril Julia, Sanyal Arun J
Center for Liver Disease and Transplantation, Columbia University Medical Center - New York Presbyterian Hospital.
Virginia Commonwealth University, VCU Medical Center.
Curr Hepatol Rep. 2016 Jun;15(2):134-139. doi: 10.1007/s11901-016-0302-1. Epub 2016 Apr 14.
Nonalcoholic fatty liver disease (NAFLD) is commonly diagnosed in obese or overweight individuals. However, lean individuals with NAFLD are not rare but represent one significant end of the phenotypic spectrum of NAFLD. Although initial observations between obese and lean NAFLD reveal some metabolic parallels, these associations vary widely given differences in study populations and metabolic parameters assessed. The role of body composition in risk assessment is significant and incompletely assessed during most clinical encounters. Recent multinational investigation reveals an increased mortality in lean individuals with NASH. Many aspects of lean NAFLD need further exploration including epidemiology, clinical risk assessment, histologic changes unique to lean NAFLD, genetic and pathophysiologic mechanisms predisposing at risk individuals, natural history and treatment strategies in this underrecognized population.
非酒精性脂肪性肝病(NAFLD)常见于肥胖或超重个体。然而,患有NAFLD的瘦人并不罕见,而是代表了NAFLD表型谱的一个重要端点。尽管肥胖和瘦型NAFLD之间的初步观察揭示了一些代谢方面的相似之处,但由于研究人群和评估的代谢参数存在差异,这些关联差异很大。在大多数临床诊疗过程中,身体组成在风险评估中的作用重大但未得到充分评估。最近的跨国调查显示,患有非酒精性脂肪性肝炎(NASH)的瘦人死亡率增加。瘦型NAFLD的许多方面都需要进一步探索,包括流行病学、临床风险评估、瘦型NAFLD特有的组织学变化、使高危个体易患的遗传和病理生理机制、这个未得到充分认识的人群的自然史和治疗策略。